"Jack Whelan is “as optimistic as ever” when it comes to treating his cancer, despite being diagnosed in 2016 with metastatic prostate cancer that hasn’t responded to traditional chemotherapy. New treatment options fuel his optimism, as they did after his 2007 diagnosis of Waldenström macroglobulinemia, a rare and incurable blood cancer. (See “Betting on Science” in the Fall 2013 issue of Cancer Today.)
Resources and information for cancer survivors in the greater New Orleans area.
Sunday, April 2, 2017
AACR Annual Meeting 2017: Community Event Features Leading Cancer Experts - Cancer Today
Cancer breakthroughs give reason for optimism, but much still needs to be done, say panelists at an AACR event in Washington, D.C.By Kevin McLaughlin
"Jack Whelan is “as optimistic as ever” when it comes to treating his cancer, despite being diagnosed in 2016 with metastatic prostate cancer that hasn’t responded to traditional chemotherapy. New treatment options fuel his optimism, as they did after his 2007 diagnosis of Waldenström macroglobulinemia, a rare and incurable blood cancer. (See “Betting on Science” in the Fall 2013 issue of Cancer Today.)
"Jack Whelan is “as optimistic as ever” when it comes to treating his cancer, despite being diagnosed in 2016 with metastatic prostate cancer that hasn’t responded to traditional chemotherapy. New treatment options fuel his optimism, as they did after his 2007 diagnosis of Waldenström macroglobulinemia, a rare and incurable blood cancer. (See “Betting on Science” in the Fall 2013 issue of Cancer Today.)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment